FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cromolyn Sodium Inhalation Solution, USP
Status: Currently in Shortage
»Date first posted: 06/21/2017
»Therapeutic Categories: Pulmonary/Allergy

Teva Pharmaceuticals (Revised 08/22/2017)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cromolyn Sodium Inhalation Solution USP, 20 mg/2 mL, 12 pouches of five 2 mL vials each (60 unit-dose vials) (NDC 0172-6406-49) Estimated availability: early November 2017 Shortage of an active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English